![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
R. M. Leadley, N. Armstrong, Y. C. Lee, A. Allen & J. Kleijnen. (2012) Chronic Diseases in the European Union: The Prevalence and Health Cost Implications of Chronic Pain. Journal of Pain & Palliative Care Pharmacotherapy 26:4, pages 310-325.
Read now
Read now
Paul C. Langley. (2012) The societal burden of pain in Germany: Health-related quality-of-life, health status and direct medical costs. Journal of Medical Economics 15:6, pages 1201-1215.
Read now
Read now
Joseph Pergolizzi, Karsten Ahlbeck, Dominic Aldington, Eli Alon, Beverly Collett, Flaminia Coluzzi, Frank Huygen, Wolfgang Jaksch, Magdalena Kocot-Kępska, Ana Cristina Mangas, Cesar Margarit, Philippe Mavrocordatos, Bart Morlion, Gerhard Müller-Schwefe, Andrew Nicolaou, Concepción Pérez Hernández, Patrick Sichere & Giustino Varrassi. (2012) The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors?. Current Medical Research and Opinion 28:2, pages 249-256.
Read now
Read now
Articles from other publishers (11)
Sarasate Eiamtanasate, Kannika Smithiseth, Nantthasorn Zinboonyahgoon, Beatrice Korwisi, Antonia BarkeWinfried Rief & Rolf-Detlef Treede. (2023) The invisible cost of pain management by the current International Classification of Diseases coding system: a study in a tertiary care inpatient setting. Pain 164:9, pages 2009-2015.
Crossref
Crossref
Dawit T. Zemedikun, Jesse Kigozi, Gwenllian Wynne-Jones, Alessandra Guariglia & Tracy Roberts. (2021) Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review. PLOS ONE 16:5, pages e0251406.
Crossref
Crossref
Davide Guido, Matilde Leonardi, Blanca Mellor-Marsá, Maria V. Moneta, Albert Sanchez-Niubo, Stefanos Tyrovolas, Iago Giné-Vázquez, Josep M. Haro, Somnath Chatterji, Martin Bobak, Jose L. Ayuso-Mateos, Holger Arndt, Ilona Koupil, Jerome Bickenbach, Seppo Koskinen, Beata Tobiasz-Adamczyk, Demosthenes Panagiotakos & Alberto Raggi. (2020) Pain rates in general population for the period 1991–2015 and 10-years prediction: results from a multi-continent age-period-cohort analysis. The Journal of Headache and Pain 21:1.
Crossref
Crossref
Mahdi Toroski, Shekoufeh Nikfar, Mohammad Mahdi Mojahedian & Mohammad Hosein Ayati. (2018) Comparison of the Cost-utility Analysis of Electroacupuncture and Nonsteroidal Antiinflammatory Drugs in the Treatment of Chronic Low Back Pain. Journal of Acupuncture and Meridian Studies 11:2, pages 62-66.
Crossref
Crossref
A. Luque Ramos & F. Hoffmann. (2016) Kassenunterschiede bei chronischen Rückenschmerzen und GelenkerkrankungenDifferences in chronic back pain and joint disorders among health insurance funds. Zeitschrift für Rheumatologie 76:3, pages 238-244.
Crossref
Crossref
Wendy TM Enthoven, Pepijn DDM Roelofs, Richard A Deyo, Maurits W van Tulder & Bart W Koes. (2016) Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Rikke Søgaard & Jan Sørensen. (2014) Health Care Costs attributable to Hospital-diagnosed Back Pain: A Longitudinal Register-based Study of the Danish Population. Journal of Health Economics and Outcomes Research 1:3, pages 266-275.
Crossref
Crossref
Enno Swart. 2014. Health Care Utilization in Germany. Health Care Utilization in Germany
63
86
.
Klaus Felix Stein & Adriana Miclescu. (2013) Effectiveness of multidisciplinary rehabilitation treatment for patients with chronic pain in a primary health care unit. Scandinavian Journal of Pain 4:4, pages 190-197.
Crossref
Crossref
Gregory P. Beehler, Amy E. Rodrigues, Denise Mercurio-Riley & Andrew S. Dunn. (2013) Primary Care Utilization among Veterans with Chronic Musculoskeletal Pain: A Retrospective Chart Review. Pain Medicine 14:7, pages 1021-1031.
Crossref
Crossref
J. Zeidler, A. Lange, S. Braun, R. Linder, S. Engel, F. Verheyen & J.-M. Graf von der Schulenburg. (2013) Die Berechnung indikationsspezifischer Kosten bei GKV-Routinedatenanalysen am Beispiel von ADHSCalculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:3, pages 430-438.
Crossref
Crossref